<DOC>
	<DOCNO>NCT01250197</DOCNO>
	<brief_summary>This double-masked , single-center , crossover study normal volunteer randomize receive one two formulation 0.5 % AR-12286 Ophthalmic Solution 8 day . Subjects undergo minimum 7-day washout , receive alternate treatment 8 day .</brief_summary>
	<brief_title>Formulation Comparison Normal Volunteers</brief_title>
	<detailed_description>Not desire .</detailed_description>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Normal volunteer Active ophthalmic systemic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Normal Volunteers</keyword>
</DOC>